Inhibition of CYP3A-mediated Midazolam Metabolism by Kaempferia Parviflora

Kaempferia parviflora (KP) extract has recently attracted attention in Japan as a dietary supplement; however, there is little information regarding food-drug interactions (FDIs). The current study was conducted to clarify the FDI of KP extract via inhibition of cytochrome P450 3A (CYP3A), a typical...

Descripción completa

Detalles Bibliográficos
Autores principales: Kashiwabuchi, Yumika, Nishimura, Yuki, Kurata, Norimitsu, Iwase, Mariko, Kiuchi, Yuji, Nobe, Koji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Food Safety Commission, Cabinet Office, Government of Japan 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008879/
https://www.ncbi.nlm.nih.gov/pubmed/35510070
http://dx.doi.org/10.14252/foodsafetyfscj.D-21-00013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008879/
https://www.ncbi.nlm.nih.gov/pubmed/35510070
http://dx.doi.org/10.14252/foodsafetyfscj.D-21-00013

Ejemplares similares